URMC / Labs / Prieto Lab / Publications Publications Hostetler GLBarber CMMiklus MBPrieto PA Determination of Casein Allergens in Extensively Hydrolyzed Casein Infant Formula by Liquid Chromatography - Tandem Mass Spectrometry.; Journal of AOAC International. 2020 Oct 16. Han BJMurphy JDQin SYe JUccello TPGarrett-Larsen JBelt BAPrieto PAEgilmez NKLord EMLinehan DCMills BNGerber SA Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma.; Immunological investigations. 2020 Jun 04. Esaa FSHobson JGMatar RNPrieto PASomers KE Toxic epidermal necrolysis after radiotherapy for pleomorphic liposarcoma.; Dermatology online journal; Vol 26(1). 2020 Jan 15. Mills BNConnolly KAYe JMurphy JDUccello TPHan BJZhao TDrage MGMurthy AQiu HPatel AFigueroa NMJohnston CJPrieto PAEgilmez NKBelt BALord EMLinehan DCGerber SA Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment.; Cell reports; Vol 29(2). 2019 Oct 08. Amaria RNMenzies AMBurton EMScolyer RATetzlaff MTAntdbacka RAriyan CBassett RCarter BDaud AFaries MFecher LAFlaherty KTGershenwald JEHamid OHong AKirkwood JMLo SMargolin KMessina JPostow MARizos HRoss MIRozeman EASaw RPMSondak VSullivan RJTaube JMThompson JFvan de Wiel BAEggermont AMDavies MAAscierto PASpillane AJvan Akkooi ACJWargo JABlank CUTawbi HALong GV Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.; The Lancet. Oncology; Vol 20(7). 2019 Jul. Patel APPeacock JLPrieto PA High-grade angiosarcoma presenting with cytology-negative hemorrhagic ascites.; Journal of surgical case reports; Vol 2018(10). 2018 Oct. Amaria RNPrieto PATetzlaff MTReuben AAndrews MCRoss MIGlitza ICCormier JHwu WJTawbi HAPatel SPLee JEGershenwald JESpencer CNGopalakrishnan VBassett RSimpson LMouton RHudgens CWZhao LZhu HCooper ZAWani KLazar AHwu PDiab AWong MKMcQuade JLRoyal RLucci ABurton EMReddy SSharma PAllison JFutreal PAWoodman SEDavies MAWargo JA Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.; The Lancet. Oncology; Vol 19(2). 2018 Feb. Gopalakrishnan VSpencer CNNezi LReuben AAndrews MCKarpinets TVPrieto PAVicente DHoffman KWei SCCogdill APZhao LHudgens CWHutchinson DSManzo TPetaccia de Macedo MCotechini TKumar TChen WSReddy SMSzczepaniak Sloane RGalloway-Pena JJiang HChen PLShpall EJRezvani KAlousi AMChemaly RFShelburne SVence LMOkhuysen PCJensen VBSwennes AGMcAllister FMarcelo Riquelme Sanchez EZhang YLe Chatelier EZitvogel LPons NAustin-Breneman JLHaydu LEBurton EMGardner JMSirmans EHu JLazar AJTsujikawa TDiab ATawbi HGlitza ICHwu WJPatel SPWoodman SEAmaria RNDavies MAGershenwald JEHwu PLee JEZhang JCoussens LMCooper ZAFutreal PADaniel CRAjami NJPetrosino JFTetzlaff MTSharma PAllison JPJenq RRWargo JA Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.; Science (New York, N.Y.); Vol 359(6371). 2018 Jan 05. Mooradian MJReuben APrieto PAHazar-Rethinam MFrederick DTNadres BPiris AJuneja VCooper ZASharpe AHCorcoran RBFlaherty KTLawrence DPWargo JASullivan RJ A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma.; Oncoimmunology; Vol 7(5). 2018. Roh WChen PLReuben ASpencer CNPrieto PAMiller JPGopalakrishnan VWang FCooper ZAReddy SMGumbs CLittle LChang QChen WSWani KDe Macedo MPChen EAustin-Breneman JLJiang HRoszik JTetzlaff MTDavies MAGershenwald JETawbi HLazar AJHwu PHwu WJDiab AGlitza ICPatel SPWoodman SEAmaria RNPrieto VGHu JSharma PAllison JPChin LZhang JWargo JAFutreal PA Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.; Science translational medicine; Vol 9(379). 2017 Mar 01. Cogdill APPrieto PAReuben AWargo JA Gene Targeting Meets Cell-Based Therapy: Raising the Tail, or Merely a Whimper?; Clinical cancer research : an official journal of the American Association for Cancer Research; Vol 23(2). 2017 Jan 15. Reuben ASpencer CNPrieto PAGopalakrishnan VReddy SMMiller JPMao XDe Macedo MPChen JSong XJiang HChen PLBeird HCGarber HRRoh WWani KChen EHaymaker CForget MALittle LDGumbs CThornton RLHudgens CWChen WSAustin-Breneman JSloane RSNezi LCogdill APBernatchez CRoszik JHwu PWoodman SEChin LTawbi HDavies MAGershenwald JEAmaria RNGlitza ICDiab APatel SPHu JLee JEGrimm EATetzlaff MTLazar AJWistuba IIClise-Dwyer KCarter BWZhang JFutreal PASharma PAllison JPCooper ZAWargo JA Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.; NPJ genomic medicine; Vol 2. 2017. Christakis IAPotylchansky ESilva AMNates JPPrieto PAGraham PHGrubbs EGLee JEPerrier ND Cervical hematoma following an endocrine surgical procedure: The MD Anderson experience.; Surgery; Vol 160(2). 2016 Aug. Chen PLRoh WReuben ACooper ZASpencer CNPrieto PAMiller JPBassett RLGopalakrishnan VWani KDe Macedo MPAustin-Breneman JLJiang HChang QReddy SMChen WSTetzlaff MTBroaddus RJDavies MAGershenwald JEHaydu LLazar AJPatel SPHwu PHwu WJDiab AGlitza ICWoodman SEVence LMWistuba IIAmaria RNKwong LNPrieto VDavis REMa WOverwijk WWSharpe AHHu JFutreal PABlando JSharma PAllison JPChin LWargo JA Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.; Cancer discovery; Vol 6(8). 2016 Aug. Starker LFPrieto PALiles JSTran Cao HSGrubbs EGLee JEPerrier NDGraham PH Endocrine incidentalomas.; Current problems in surgery; Vol 53(5). 2016 May. Cooper ZAReuben ASpencer CNPrieto PAAustin-Breneman JLJiang HHaymaker CGopalakrishnan VTetzlaff MTFrederick DTSullivan RJAmaria RNPatel SPHwu PWoodman SEGlitza ICDiab AVence LMRodriguez-Canales JParra ERWistuba IICoussens LMSharpe AHFlaherty KTGershenwald JEChin LDavies MAClise-Dwyer KAllison JPSharma PWargo JA Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma.; Oncoimmunology; Vol 5(3). 2016 Mar. Prieto PAReuben ACooper ZAWargo JA Targeted Therapies Combined With Immune Checkpoint Therapy.; Cancer journal (Sudbury, Mass.); Vol 22(2). 2016 Mar. Lebastchi AHPrieto PAChen CLui FY Appendiceal endometriosis in a pregnant woman presenting with acute perforated appendicitis.; Journal of surgical case reports; Vol 2013(12). 2013 Dec 16. Prieto PACha CH DKK1 as a serum biomarker for hepatocellular carcinoma.; Hepatobiliary surgery and nutrition; Vol 2(3). 2013 Jun. Friedman KMPrieto PADevillier LEGross CAYang JCWunderlich JRRosenberg SADudley ME Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes.; Journal of immunotherapy (Hagerstown, Md. : 1997); Vol 35(5). 2012 Jun. Prieto PAYang JCSherry RMHughes MSKammula USWhite DELevy CLRosenberg SAPhan GQ CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma.; Clinical cancer research : an official journal of the American Association for Cancer Research; Vol 18(7). 2012 Apr 01. Langan RCRipley RTDavis JLPrieto PADatrice NSteinberg SMBratslavsky GRudloff UKammula USStojadinovic AAvital I Liver directed therapy for renal cell carcinoma.; Journal of Cancer; Vol 3. 2012. Langan RCPrieto PASherry RMZlott DWunderlich JCsako GCostello RWhite DERosenberg SAYang JC Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy.; Journal of immunotherapy (Hagerstown, Md. : 1997); Vol 34(4). 2011 May. Dudley MEGross CALanghan MMGarcia MRSherry RMYang JCPhan GQKammula USHughes MSCitrin DERestifo NPWunderlich JRPrieto PAHong JJLangan RCZlott DAMorton KEWhite DELaurencot CMRosenberg SA CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma.; Clinical cancer research : an official journal of the American Association for Cancer Research; Vol 16(24). 2010 Dec 15. Prieto PADurflinger KHWunderlich JRRosenberg SADudley ME Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy.; Journal of immunotherapy (Hagerstown, Md. : 1997); Vol 33(5). 2010 Jun.